Renee A Butler

There are more than 7,000 rare diseases in existence right now and together they impact millions of people around the world. However, individually, a rare disease can be defined as impacting fewer than 5 in 10,000. When indications are that sparse, developing treatments for rare diseases is challenging. Choosing the right location can make a difference. While the right site location will vary depending on the indication, some parts of the world are particularly well-suited to rare disease res...

Medicine is continually advancing. New bodily mechanisms are uncovered and understood as analytical platforms improve. It happens almost by a zeitgeist, with several locations around the world happening upon similar discoveries and subsequent researchers leveraging those findings to prompt an evolution of those understandings. The transformation manifests by a sudden influx of publications describing the phenomenon, but this change is evident in the volume of work surrounding the discovery. I...

Managing the COVID-19 pandemic has prompted countries and regions around the world to introduce a series of adaptions. For the most part, business as usual is underway, but some areas of life are still heavily impacted. One of the most significant issues for clinical research is patient recruitment and subject participation.
The Slow Road Out of Lockdown
Since March 2020, over 500 companies have announced that clinical trials were disrupted because of COVID-19 restrictions. While most of thes...

HOUSTON, Texas, May 10, 2021 – Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for infectious diseases, vaccines, rare and orphan diseases along with oncology, is now enrolling volunteers in the United Kingdom into a pivotal Phase III COVID-19 vaccine study. Visit ukcovid19study.com for more information about participation.
The Phase III “Cov-Compare” trial (VLA2001-301) will compare Valneva’s SARS-CoV-2 vaccine candidate, VLA2001, against AstraZeneca’s...

Rare disease research can take many forms, and each drug development platform offers specific advantages researchers can leverage to address elements of these conditions. Earlier, we began to discuss research within the field of rare disease (read the article here). We reviewed an article from Nature (you can access it here) and went in detail about specific types of rare disease research in subsequent articles. At this point, we have covered small molecules (click here) and antibody therapy ...

The growth of online sales as a percentage of all retail continues to grow, but ecommerce itself is beginning to mature — and that online retailers were having to change their business models to reflect that. Whereas a novel concept or a low price was once enough to get customers to visit the site, the maturity of the channel meant that companies needed to shift their focus towards more sophisticated analysis that examines more fragmented ways visitors find their site and the rate at which th...

Finding a company for a good long position and a little regular income is not an easy feat. The larger dividend yields tend to be offered by mature companies with little debt that may not need to reinvest all of their earnings. Retaining that cash would have resulted in a cash surplus and shifted the companies’ capital structures. It also helps attract investors when year over year growth is not very high.

Month over month construction spending is contracting, particularly in private construction and home improvement, and that could spell trouble for companies in the home improvement industry.

Spending on home improvement projects fell almost 2% in May while private construction spending was down 1.5%. "The recent flattening out in housing activity could prove more protracted than currently expected rather than resuming its earlier pace of recovery," said Federal Reserve Chair Janet Yellen in May. She continued by warning that housing activity has been disappointing this year...

Business owners tend to develop strong relationships with their accountants. usually at least once a quarter you sit down to figure out where your company stands and how much it owes in taxes. You might also meet a couple times a year to plan when you will make certain investments in your business or how you will structure wages so that you get the greatest tax benefit.